SPOTLIGHT -
Last summer, Pfizer Inc. announced it was selling the surgical ophthalmic business acquired in the acquisition of Pharmacia Inc. (See Ophthalmology Times, Sept. 1, 2003 issue, Page 3).
Orbis, FundamentalVR team up to target training
(EyePod) From idea to impact: Navigating ophthalmic innovation
ARVO flying high in Seattle
EyePod: Modifier Gene Therapy: What is it?
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease
Using extracellular vesicles in the treatment of ocular diseases